Iktos
Iktos is a French company pioneering AI and robotics to transform drug discovery by integrating generative AI, retrosynthesis AI, and autonomous lab robotics. Their SaaS platforms Makya and Spaya enable novel molecule design and efficient synthesis planning, while their robotic systems automate synthesis, purification, and biological testing. This integrated approach accelerates drug candidate development to under two years, serving pharmaceutical, biotech, and academic partners through over 60 collaborations. Iktos also develops its own drug pipeline targeting oncology, inflammation, and metabolism, positioning itself as a leader in AI-driven drug discovery innovation.
Iktos
Iktos is a French company pioneering AI and robotics to transform drug discovery by integrating generative AI, retrosynthesis AI, and autonomous lab robotics. Their SaaS platforms Makya and Spaya enable novel molecule design and efficient synthesis planning, while their robotic systems automate synthesis, purification, and biological testing. This integrated approach accelerates drug candidate development to under two years, serving pharmaceutical, biotech, and academic partners through over 60 collaborations. Iktos also develops its own drug pipeline targeting oncology, inflammation, and metabolism, positioning itself as a leader in AI-driven drug discovery innovation.